Efficacy of Xiidra in Dry Eye Disease After Collagen Cross Linking

Status Recruiting

Clinical Trial Summary

dry eye disease after corneal collagen cross linking affect ocular function leading to reduced vision, photophobia, glare, halos, and foreign body sensation.

Clinical Trial Description

first group of patients were treated with 0.5 % xiidra twice daily and artificial tears for 6 months.Second group treated with artificial tears for 6 months. the treatment starts after corneal collagen cross linking in both groups ,Baseline and post-treatment full ophthalmic examination was done. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05045053
Study type	Interventional
Source	Benha University
Contact	Tarek R Elhamaky, M.D.
Phone	+971 503207889
Email	dr_thamakyy@yahoo.com
Status	Recruiting
Phase	Phase 4
Start date	February 1, 2021
Completion date	January 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05114928` - Correlation Between Q-value Changes and Progression of Pediatric Keratoconus.
Recruiting	`NCT06160960` - Influence of Pupillary Behavior During Eye Surgery on Morphological and Functional Outcome
Completed	`NCT00357435` - Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Completed	`NCT04484402` - Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells	Phase 1/Phase 2
Not yet recruiting	`NCT05581875` - A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory	Phase 1/Phase 2
Recruiting	`NCT06101017` - Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease
Withdrawn	`NCT03421548` - Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1	N/A
Withdrawn	`NCT05700864` - NGF Treatment for Patients With Neuropathic Corneal Pain	Phase 1
Enrolling by invitation	`NCT05758753` - QST for Corneal Nerve Function	N/A
Terminated	`NCT00001310` - Tissue Studies of Human Eye Diseases
Completed	`NCT02386774` - Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa	N/A
Recruiting	`NCT05694247` - Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness	N/A
Not yet recruiting	`NCT06294015` - Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.	Phase 4
Completed	`NCT00654888` - Automated Lamellar Keratectomy in Symptomatic Patients With Bullous Keratopathy	N/A
Recruiting	`NCT04251143` - Dresden Corneal Disease and Treatment Study
Withdrawn	`NCT02374723` - Evaluation of Biosynthetic Constructs to Replace Donor Corneas	Phase 1
Completed	`NCT01384487` - Nidek RS3000 Comparative Study	N/A
Completed	`NCT00804505` - Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study	N/A
Completed	`NCT04475900` - Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
Recruiting	`NCT05573802` - A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma	Phase 1/Phase 2